查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球脊髓創傷治療市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按治療類型、按損傷類型、按最終用戶、按地區
市場調查報告書
商品編碼
1413742

全球脊髓創傷治療市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按治療類型、按損傷類型、按最終用戶、按地區

Spinal Cord Trauma Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 183 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

2024年至2031年，全球脊椎創傷治療市場規模顯著成長，預計將維持這種上升趨勢。

影響中東和非洲脊髓創傷治療市場成長的挑戰之一是專業治療中心數量有限。脊髓損傷主要在急診室和創傷中心治療，但該地區使用這些設施的機會不足。獲得適當治療設施的機會有限阻礙了市場的成長，由於非洲獲得緊急醫療服務的機會有限，遭受脊髓創傷的患者面臨更高的風險。

手術是目前治療脊髓損傷的標準方法，但它不能治癒這種疾病，只能防止其惡化。在亞太地區，很大一部分人口缺乏醫療保險，迫使病人自掏腰包支付手術費用。這些手術的高成本和有限的療效阻礙了患者及其家人選擇手術治療，這對市場成長構成了挑戰。

目前歐洲使用的療法在改善脊椎創傷患者的病情方面療效有限。因此，人們越來越多地投資開發替代療法，以提供更好的護理並改善患者的治療效果。目前正在進行研究，探索幹細胞療法和神經再生療法等選擇。這些治療方法的開發預計將減少對效果較差的治療方法的依賴，並阻礙傳統手術市場的成長。

該報告研究了全球脊髓創傷治療市場，並提供了市場概述，包括按治療類型、損傷類型、最終用戶、地區以及進入市場的公司的競爭趨勢劃分的趨勢。

目錄

第一章執行摘要

第二章市場概況

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • COVID-19 影響分析
  • 烏克蘭與俄羅斯衝突的影響
  • 經濟概況
  • PESTLE分析

第三章2018-2031年全球脊椎創傷治療市場展望

  • 全球脊椎創傷治療市場展望，依治療類型、價值（十億美元），2018-2031
  • 全球脊椎創傷治療市場展望，依損傷類型、價值（十億美元），2018-2031
  • 全球脊椎創傷治療市場展望，按最終用戶劃分，價值（十億美元），2018-2031
  • 全球脊椎創傷治療市場展望，按地區，價值（十億美元），2018-2031

第四章 2018-2031 北美脊椎創傷治療市場展望

第五章歐洲脊椎創傷治療市場展望，2018-2031

第六章 2018-2031 亞太地區脊椎創傷治療市場展望

第七章 2018-2031 拉丁美洲脊椎創傷治療市場展望

第 8 章 2018-2031 年中東和非洲脊椎創傷治療市場展望

第9章 競爭格局

  • 治療類型和最終用戶的熱圖
  • 製造商和最終用戶熱圖
  • 2023 年公司市場份額分析
  • 比賽儀表板
  • 公司簡介
    • Acorda Therapeutics, Inc.
    • Asterias Biotherapeutics
    • ReNetX Bio.
    • BioArctic AB
    • BioTime, Inc.
    • InVivo Therapeutics
    • Kringle Pharma, Inc.
    • Novartis AG
    • Pfizer Inc.
    • Pharmicell Co. Ltd.
    • Vertex Pharmaceuticals Inc.
    • Bioaxone Biosciences, Inc.

第10章附錄

簡介目錄

The global market for the treatment of spinal cord trauma has experienced substantial growth from 2024 to 2031, and it is expected to maintain this upward trajectory. A comprehensive research report by Fairfield Market Research also indicates the presence of a significant absolute dollar opportunity, along with an incremental opportunity between 2024 and 2031.

Challenges in the Middle East & Africa

One of the challenges affecting the growth of the spinal cord trauma treatment market in the Middle East & Africa is the limited number of specialized treatment centers. Spinal cord trauma is primarily treated in emergency units and trauma centers, but the region lacks sufficient access to these facilities. Limited availability of proper treatment facilities is hindering the market's growth, and individuals suffering from spinal cord trauma in Africa face higher risks due to restricted access to emergency healthcare.

Cost Barriers in the Asia-Pacific Region

Surgical procedures are the current standard for treating spinal cord injuries, but they do not cure the disorder; they only prevent its worsening. In the Asia-Pacific region, a significant portion of the population lacks healthcare insurance coverage, forcing patients to bear the cost of procedures themselves. The high expense of these procedures and their limited effectiveness are discouraging patients and their families from opting for surgical treatment, posing a challenge to market growth.

Rising Focus on Alternative Treatments in Europe

The treatment modalities currently used in Europe have limited therapeutic impact on improving the condition of patients with spinal cord trauma. Consequently, there is increasing investment in the development of alternative treatment modalities to provide better care and enhance patient outcomes. Research efforts are underway to explore options such as stem cell therapy and nerve regeneration therapy. The development of these therapies is expected to reduce the reliance on less effective treatment methods, thus hampering the growth of the traditional surgery market.

Ineffectiveness of Surgery in Latin America

In Latin American countries, financial considerations play a significant role in determining the preferred treatment approach for spinal cord trauma. Given that surgical procedures cannot completely cure the condition but only prevent its worsening, patients and their families may opt for alternatives when surgery is deemed ineffective. This ineffectiveness of spinal surgery in delivering the required cure is a factor limiting market growth in the region.

Availability of Alternative Treatments in North America

The most preferred treatments for spinal cord trauma in North America involve corticosteroids, spinal traction, and decompression surgical procedures. However, these procedures cannot reverse the damage to the spinal cord. To address this, various biopharmaceutical and medical devices companies in North America are developing alternative treatment options aimed at improving sensory function and treating damaged nerves. The availability of these alternative treatment modalities is expected to restrain the growth of the traditional spinal cord trauma treatment market.

Market Segmentation

By Treatment Type

  • Corticosteroid
  • Surgery
  • Spinal Traction

By Injury Type

  • Complete Spinal Cord Injuries
  • Partial Spinal Cord Injuries

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

By End User

  • Hospitals
  • Trauma Centers

Table of Contents

1. Executive Summary

  • 1.1. Global Spinal Cord Trauma Treatment Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Spinal Cord Trauma Treatment Market Outlook, 2018 - 2031

  • 3.1. Global Spinal Cord Trauma Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Corticosteroid
      • 3.1.1.2. Surgery
      • 3.1.1.3. Spinal Traction
  • 3.2. Global Spinal Cord Trauma Treatment Market Outlook, by Injury Type, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Complete Spinal Cord Injuries
      • 3.2.1.2. Partial Spinal Cord Injuries
  • 3.3. Global Spinal Cord Trauma Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Hospitals
      • 3.3.1.2. Trauma Centers
  • 3.4. Global Spinal Cord Trauma Treatment Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. North America
      • 3.4.1.2. Europe
      • 3.4.1.3. Asia Pacific
      • 3.4.1.4. Latin America
      • 3.4.1.5. Middle East & Africa

4. North America Spinal Cord Trauma Treatment Market Outlook, 2018 - 2031

  • 4.1. North America Spinal Cord Trauma Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Corticosteroid
      • 4.1.1.2. Surgery
      • 4.1.1.3. Spinal Traction
  • 4.2. North America Spinal Cord Trauma Treatment Market Outlook, by Injury Type, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Complete Spinal Cord Injuries
      • 4.2.1.2. Partial Spinal Cord Injuries
  • 4.3. North America Spinal Cord Trauma Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Trauma Centers
  • 4.4. North America Spinal Cord Trauma Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. U.S. Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 4.4.1.2. U.S. Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 4.4.1.3. U.S. Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 4.4.1.4. Canada Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 4.4.1.5. Canada Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 4.4.1.6. Canada Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Spinal Cord Trauma Treatment Market Outlook, 2018 - 2031

  • 5.1. Europe Spinal Cord Trauma Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Corticosteroid
      • 5.1.1.2. Surgery
      • 5.1.1.3. Spinal Traction
  • 5.2. Europe Spinal Cord Trauma Treatment Market Outlook, by Injury Type, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Complete Spinal Cord Injuries
      • 5.2.1.2. Partial Spinal Cord Injuries
  • 5.3. Europe Spinal Cord Trauma Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Trauma Centers
  • 5.4. Europe Spinal Cord Trauma Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Germany Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.2. Germany Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.3. Germany Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.4. U.K. Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.5. U.K. Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.6. U.K. Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.7. France Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.8. France Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.9. France Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.10. Italy Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.11. Italy Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.12. Italy Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.13. Turkey Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.14. Turkey Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.15. Turkey Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.16. Russia Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.17. Russia Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.18. Russia Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 5.4.1.19. Rest of Europe Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.20. Rest of Europe Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 5.4.1.21. Rest of Europe Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Spinal Cord Trauma Treatment Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Spinal Cord Trauma Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Corticosteroid
      • 6.1.1.2. Surgery
      • 6.1.1.3. Spinal Traction
  • 6.2. Asia Pacific Spinal Cord Trauma Treatment Market Outlook, by Injury Type, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Complete Spinal Cord Injuries
      • 6.2.1.2. Partial Spinal Cord Injuries
  • 6.3. Asia Pacific Spinal Cord Trauma Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Trauma Centers
  • 6.4. Asia Pacific Spinal Cord Trauma Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. China Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.2. China Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.3. China Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.4. Japan Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.5. Japan Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.6. Japan Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.7. South Korea Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.8. South Korea Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.9. South Korea Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.10. India Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.11. India Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.12. India Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.13. Southeast Asia Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.14. Southeast Asia Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.15. Southeast Asia Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 6.4.1.16. Rest of Asia Pacific Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.17. Rest of Asia Pacific Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 6.4.1.18. Rest of Asia Pacific Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Spinal Cord Trauma Treatment Market Outlook, 2018 - 2031

  • 7.1. Latin America Spinal Cord Trauma Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Corticosteroid
      • 7.1.1.2. Surgery
      • 7.1.1.3. Spinal Traction
  • 7.2. Latin America Spinal Cord Trauma Treatment Market Outlook, by Injury Type, Value (US$ Bn), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Complete Spinal Cord Injuries
      • 7.2.1.2. Partial Spinal Cord Injuries
  • 7.3. Latin America Spinal Cord Trauma Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Trauma Centers
  • 7.4. Latin America Spinal Cord Trauma Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Brazil Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.2. Brazil Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.3. Brazil Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.4. Mexico Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.5. Mexico Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.6. Mexico Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.7. Argentina Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.8. Argentina Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.9. Argentina Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 7.4.1.10. Rest of Latin America Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.11. Rest of Latin America Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 7.4.1.12. Rest of Latin America Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Spinal Cord Trauma Treatment Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Spinal Cord Trauma Treatment Market Outlook, by Treatment Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Corticosteroid
      • 8.1.1.2. Surgery
      • 8.1.1.3. Spinal Traction
  • 8.2. Middle East & Africa Spinal Cord Trauma Treatment Market Outlook, by Injury Type, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Complete Spinal Cord Injuries
      • 8.2.1.2. Partial Spinal Cord Injuries
  • 8.3. Middle East & Africa Spinal Cord Trauma Treatment Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Trauma Centers
  • 8.4. Middle East & Africa Spinal Cord Trauma Treatment Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. GCC Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.2. GCC Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.3. GCC Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.4. South Africa Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.5. South Africa Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.6. South Africa Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.7. Egypt Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.8. Egypt Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.9. Egypt Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.10. Nigeria Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.11. Nigeria Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.12. Nigeria Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
      • 8.4.1.13. Rest of Middle East & Africa Spinal Cord Trauma Treatment Market by Treatment Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.14. Rest of Middle East & Africa Spinal Cord Trauma Treatment Market by Injury Type, Value (US$ Bn), 2018 - 2031
      • 8.4.1.15. Rest of Middle East & Africa Spinal Cord Trauma Treatment Market End User, Value (US$ Bn), 2018 - 2031
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Treatment Type vs End User Heatmap
  • 9.2. Manufacturer vs End User Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Acorda Therapeutics, Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Treatment Type Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Asterias Biotherapeutics
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Treatment Type Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. ReNetX Bio.
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Treatment Type Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. BioArctic AB
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Treatment Type Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. BioTime, Inc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Treatment Type Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. InVivo Therapeutics
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Treatment Type Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Kringle Pharma, Inc.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Treatment Type Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Novartis AG
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Treatment Type Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Pfizer Inc.
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Treatment Type Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Pharmicell Co. Ltd.
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Treatment Type Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Vertex Pharmaceuticals Inc.
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Treatment Type Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Bioaxone Biosciences, Inc.
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Treatment Type Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations